Literature DB >> 30633671

How Is Telemedicine Being Used In Opioid And Other Substance Use Disorder Treatment?

Haiden A Huskamp1, Alisa B Busch2, Jeffrey Souza3, Lori Uscher-Pines4, Sherri Rose5, Andrew Wilcock6, Bruce E Landon7, Ateev Mehrotra8.   

Abstract

Only a small proportion of people with a substance use disorder (SUD) receive treatment. The shortage of SUD treatment providers, particularly in rural areas, is an important driver of this treatment gap. Telemedicine could be a means of expanding access to treatment. However, several key regulatory and reimbursement barriers to greater use of telemedicine for SUD (tele-SUD) exist, and both Congress and the states are considering or have recently passed legislation to address them. To inform these efforts, we describe how tele-SUD is being used. Using claims data for 2010-17 from a large commercial insurer, we identified characteristics of tele-SUD users and examined how tele-SUD is being used in conjunction with in-person SUD care. Despite a rapid increase in tele-SUD over the study period, we found low use rates overall, particularly relative to the growth in telemental health. Tele-SUD is primarily used to complement in-person care and is disproportionately used by those with relatively severe SUD. Given the severity of the opioid epidemic, low rates of tele-SUD use represent a missed opportunity. As tele-SUD becomes more available, it will be important to monitor closely which tele-SUD delivery models are being used and their impact on access and outcomes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30633671      PMCID: PMC6671682          DOI: 10.1377/hlthaff.2018.05134

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  46 in total

1.  Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment.

Authors:  Alisa B Busch; Shelly F Greenfield; Sharon Reif; Sharon-Lise T Normand; Haiden A Huskamp
Journal:  J Subst Abuse Treat       Date:  2020-05-22

2.  Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019: Recommendations to Enhance Adoption.

Authors:  Lewei Allison Lin; Anne C Fernandez; Erin E Bonar
Journal:  JAMA Psychiatry       Date:  2020-12-01       Impact factor: 21.596

3.  Telemental Health and US Rural-Urban Differences in Specialty Mental Health Use, 2010-2017.

Authors:  Sadiq Y Patel; Haiden A Huskamp; Alisa B Busch; Ateev Mehrotra
Journal:  Am J Public Health       Date:  2020-07-16       Impact factor: 9.308

4.  Policies to Improve Substance Use Disorder Treatment With Telehealth During the COVID-19 Pandemic and Beyond.

Authors:  Coleman Drake; Jiani Yu; Nicole Lurie; Kevin Kraemer; Daniel Polsky; Krisda H Chaiyachati
Journal:  J Addict Med       Date:  2020 Sep/Oct       Impact factor: 3.702

5.  Health center implementation of telemedicine for opioid use disorders: A qualitative assessment of adopters and nonadopters.

Authors:  Lori Uscher-Pines; Pushpa Raja; Ateev Mehrotra; Haiden A Huskamp
Journal:  J Subst Abuse Treat       Date:  2020-05-13

6.  Association Between Telepsychiatry Capability and Treatment of Patients With Mental Illness in the Emergency Department.

Authors:  Sadiq Y Patel; Haiden A Huskamp; Michael L Barnett; José R Zubizarreta; Kori S Zachrison; Alisa B Busch; Andrew D Wilcock; Ateev Mehrotra
Journal:  Psychiatr Serv       Date:  2021-08-19       Impact factor: 3.084

7.  Geographic access to buprenorphine prescribers for patients who use public transit.

Authors:  C Drake; J M Donohue; D Nagy; C Mair; K L Kraemer; D J Wallace
Journal:  J Subst Abuse Treat       Date:  2020-08-05

8.  Clinicians' Perceptions of Rapid Scale-up of Telehealth Services in Outpatient Mental Health Treatment.

Authors:  Dawn E Sugarman; Lisa E Horvitz; Shelly F Greenfield; Alisa B Busch
Journal:  Telemed J E Health       Date:  2021-02-18       Impact factor: 3.536

9.  Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder.

Authors:  Lewei A Lin; John C Fortney; Amy S B Bohnert; Lara N Coughlin; Lan Zhang; John D Piette
Journal:  J Subst Abuse Treat       Date:  2021-05-28

10.  Impact of the Coronavirus Pandemic on Substance Use Disorder Treatment: Findings from a Survey of Specialty Providers in California.

Authors:  Kristen Henretty; Howard Padwa; Katherine Treiman; Marylou Gilbert; Tami L Mark
Journal:  Subst Abuse       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.